Therefore, the search for genetic biomarkers for AD, in combination with amyloid, tau, and microglial PET imaging and genetic marker detection, is important for the comprehensive diagnosis of AD and the identification of potential therapeutic targets for AD (35). The gene discussed is MAPT; the disease is Alzheimer disease.